Vimarsana
Biggest News Aggregation in the World

Gene Expression Regulation Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gene Expression Regulation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gene Expression Regulation Program Today - Breaking & Trending Today

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus - Vimarsana News

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus

Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.

Wistar Researchers Discover Potential Target for Gastric - Vimarsana News

Wistar Researchers Discover Potential Target for Gastric

PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers...

Wistar researchers discover potential target - Vimarsana News

Wistar researchers discover potential target

Wistar Institute scientists have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.

Wistar Researchers Discover Potential Target for Gastric - Vimarsana News

Wistar Researchers Discover Potential Target for Gastric

PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers...

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus - Vimarsana News

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).